Esta guía de implementación resume las recomendaciones globales actuales y las consideraciones programáticas para establecer o fortalecer plataformas para la vacunación de los trabajadores de la salud. Está destinada a los responsables de la...

Ce guide de mise en œuvre a pour but de résumer les recommandations mondiales actuelles et les considérations programmatiques pour la mise en place ou le renforcement des plates-formes de vaccination des personnels de santé. Il est destiné...

JSI, VillageReach (VR) and CHAI collaborated across several countries and supply chains to explore the challenges of dissemination, interpretation and use of global technical goods.

This implementation guidance summarizes and builds on current global recommendations and programmatic considerations for establishing and/or strengthening platforms for the vaccination of health workers. It is intended for policy...

This interim guidance for vaccination to help stop the monkeypox outbreak is provided to support the global response to an evolving situation. For information on different vaccines that may be available, consult the background section which follows...

In 2020, Ghana's switched from ROTARIX to ROTAVAC in its routine immunization program in order to save money and cold chain space. An economic analysis of this switch, conducted by PATH, the University of Ghana, and Ghana Health Service, found that...

Conformément à son mandat, qui prévoit qu’elle conseille les États Membres en matière de politique sanitaire, l’OMS publie une série de notes de synthèse régulièrement mises à jour sur les vaccins et les associations vacci- nales...

La vaccination antirotavirus en Palestine a considérablement fait diminuer la charge de morbidité que représente la diarrhée chez les enfants, et ses bénéfices ont été renforcés par un changement de vaccin. Les résultats de cette analyse...

Strategic intent for Preferred Policy Profiles and proposed test cases

To set out an overarching global vision and strategy for vaccines and immunization for the decade 2021–2030.

Preventable disease, emerging infectious disease, extreme weather-related disasters due to urbanization and environmental degradation, and complications of pregnancy and childbirth still claim far too many lives and challenge the ability of health...

The BID Learning Network invites you to view a webinar presentation on The Immunization Data: Evidence for Action (IDEA) Review. IDEA is a global synthesis of existing evidence aimed at increasing the use of high-quality data to improve immunization...

The BID Learning Network invites you to view a webinar presentation on The Data Use Partnership. The use of reliable information from a well-designed health information system is critical for: decision-making during disease outbreaks; enhancing...

Just as medical doctors take the Hippocratic Oath as they graduate into their profession, so do many engineers solemnly promise to carry out work to the highest quality, recognizing that any errors may put lives at stake. Given this sharing of...

Sustainability has been a core principle of the BID Initiative from its earliest days. Planning for sustainability focuses on four key areas: policy, institutional factors, technical issues, and financial considerations.

The Community Preventive Services Task Force (CPSTF) recommends standing orders for vaccinations—when used alone or when combined with additional interventions—to increase vaccination rates among adults and children from different populations or...

The sample job aid is adapted from Timor Leste (IMMUNIZATIONbasics, 2007) and is based on a child immunization schedule that calls for BCG and hepatitis B at birth; Pentavalent, oral polio vaccine (OPV), pneumococcal conjugate vaccine (PCV), and...

Ending Cholera—A Global Roadmap to 2030 operationalises the new global strategy for cholera control at the country level and provides a concrete path toward a world in which cholera is no longer a threat to public health. By implementing the...

WHO’s Vision and Mission in Immunization and Vaccines 2015-2030 describes WHO’s strategic focus and key roles in achieving the goals of the Global Vaccine Action Plan 2011-2020, across all areas of work and all levels of the organization, in...

You will find here 3 documents: 1- WHO/UNICEF Joint Communique – Replacement of TT with Td vaccine for dual protection 2- WHO/UNICEF GUIDANCE NOTE Ensuring Sustained Protection Against Diphtheria: Replacing TT with Td vaccine 3- Frequently...

The Strategic Advisory Group of Experts (SAGE) on Immunization was established by the Director-General of the World Health Organization in 1999 to provide guidance on the work of WHO. SAGE is the principal advisory group to WHO for vaccines and...

This information bulletin addresses the implications and required guidance associated with the upcoming scheduled shift in vaccine vial monitor (VVM) of the GlaxoSmithKline Biologicals SA (GSK) Rotavirus vaccine, Rotarix®, from VVM type 14 (VVM14)...

This guidance note for National Immunization Programmes aims to: Present considerations regarding the involvement of nongovernmental (private) providers in vaccine delivery (including contribution to enhancing coverage and equity while...

Improving evidence informed decision-making in immunisation is a global health priority and many low and middle-income countries have established National Immunisation Technical Advisory Groups (NITAGs) as independent technical advisory bodies for...

To empower governments to formulate rational policies without pressure from any group, and to increasethe use of evidence-based decision-making to adapt global recommendations on immunization to theirlocal context, the WHO has recommended on...

The HPV Vaccine Introduction Clearing House is a unique space to find WHO publications, tools and other important resources on the human papillomavirus vaccine. The purpose is to help guide HPV vaccine policy, programme and communications...

WHO and UNICEF strongly recommend the systematic and exclusive use of auto-disable (AD) syringes for the delivery of vaccines and reuse prevention syringes (RUP) for the reconstitution of vaccines during routine immunization services and mass...

Measles, a vaccine-preventable illness, is one of the most infectious diseases known to man. In 2015, an estimated 134,200 measles deaths occurred globally. Rubella, also vaccine-preventable, is a concern because infection during pregnancy can...

Background: Vaccination rates have remained steady for a number of years in Australia, however geographical areas of lower vaccine coverage remains a day-to-day challenge. The study explores parental attitudes, beliefs and intentions in relation to...

With social policies increasingly directed toward enhancing equity through health programs, it is important that methods for estimating the health and economic benefits of these programs by subpopulation be developed, to assess both equity concerns...

Rates of vaccine-preventable diseases have increased in the United States in recent years, largely due to parental refusals of recommended childhood immunizations. Empirical studies have demonstrated a relationship between nonvaccination rates and...

This review focuses on existing immunization policies and practices for migrants and refugees and provides an overview of barriers and facilitators for access to and utilization of immunization services. Evidence was obtained by a scoping review of...

In light of the increasing refusal of some parents to vaccinate children, public health strategies have focused on increasing knowledge and awareness based on a “knowledge-deficit” approach. However, decisions about vaccination are based on more...

Following the 2010 earthquake, Haiti was at heightened risk for vaccine-preventable diseases (VPDs) outbreaks due to the exacerbation of long-standing gaps in the vaccination program and subsequent risk of VPD importation from other countries....

Aid to health has been instrumental in improving health outcomes in many places; however, all of these gains could be undone by a mismanaged donor transition. If donors transition too early, or en masse, then the health system which they have helped...

There is an enhanced focus on considering the full public health value (FPHV) of vaccination when setting priorities, making regulatory decisions and establishing implementation policy for public health activities. Historically, a therapeutic...

This study examined the dynamics of vaccine spending and vaccine legislation in the Americas Region over the period 1980-2013. Annual vaccine expenditures from thirty-one countries were extracted from the Pan American Health Organization Revolving...

There is growing controversy about vaccination rates in Canada. A significant percentage of the population is uncertain about the science of vaccines, and in some areas ‘herd immunity\' is being threatened. Hesitancy to vaccinate is a complex...

The Sabin Vaccine Institute, in collaboration with international partners and the Government of Georgia, organized a Workshop on Immunization Legislation that gathered the three European countries of Sabin’s Sustainable Immunization Financing...

The recent inauguration of President Trump carries with it many public health policy implications. During the election, President Trump, like all political candidates, made policy commitments to various interest groups including vaccine skeptics....

In 2013, the Council for International Organizations of Medical Sciences (CIOMS) created a Working Group on Vaccine Safety (WG) to address unmet needs in the area of vaccine pharmacovigilance. Generating reliable data about specific vaccine safety...

Background: Equity remains a priority in the international health development agenda. However, major inequities in vaccination coverage jeopardise the achievement of the Sustainable Development Goals. We aim at comprehensively describing how...

The current WHO position on the use of yellow fever (YF) vaccine is set out in the 2013 WHO position paper on vaccines and vaccination against YF and those recommendations are unchanged. This addendum to the 2013 position paper pertains...

Case-control studies are commonly used to evaluate effectiveness of licensed vaccines after deployment in public health programs. Such studies can provide policy-relevant data on vaccine performance under ‘real world’ conditions, contributing to...

Introduction: The vaccine vial monitor (VVM) registers cumulative heat exposure on vaccines over time. As low- and lower-middle-income countries transition beyond support from the Global Alliance for Vaccines and Immunization (Gavi), they will...

As immunization programs around the world undergo rapid change and expansion, supply chain and logistics systems have become strained, making it increasingly challenging for national public health systems to provide reliable, safe, and efficient...

This article aims to understand why the last few areas where polio remains are affected by armed conflicts involving militant organizations that use Islam to legitimize their activities. The first section critically analyses the argument that...

5.9 million children under 5 died in 2015, the majority from vaccine preventable diseases. Decades of effort & investment from donor countries have driven significant progress but, in the final year of the Millennium Development Goals, 19.4 million...

Objectives: To determine the lifetime social value of using the guideline-recommended vaccines for children born in the United States in 2009. Study Design: This study utilized an economic model with parameter values sourced from clinical and...

Developed jointly by UNICEF and WHO, this brief \"MDVP\" mini-course provides all partners and staff working to support immunization with a better understanding of the 2014 revision of the Multi-Dose Vial Policy and how to apply it in the real...